Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for ...

Retrieved on: 2024-04-09 19:05:08

Tags for this article:

Click the tags to see associated articles and topics

Lonza, NeuroSense Strike Deal Focused on Exploring Biological Markers for .... View article details on HISWAI: https://www.pharmexec.com/view/lonza-neurosense-strike-deal-focused-on-exploring-biological-markers-for-neurodegenerative-diseases

Summary

Lonza and NeuroSense Therapeutics collaborate to utilize extracellular vesicles, specifically neuron-derived exosomes, to develop biomarkers for ALS, aiming to improve neurodegenerative disease treatments with support from Merit Cudkowicz.

Article found on: www.pharmexec.com

View Original Article